Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentChange in Account PayablesChange in Accured ExpensesChange in TaxesGains from Equity InvestmentsNet IncomeNon-cash Items
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zepp Health (ZEPP) Gains from Sales and Divestitures: 2016-2023

  • Zepp Health's Gains from Sales and Divestitures rose 25.90% to $224,537 in Q4 2023 from the same period last year, while for Dec 2023 it was $224,537, marking a year-over-year increase of 25.90%. This contributed to the annual value of $228,765 for FY2023, which is 21.09% up from last year.
  • Zepp Health's Gains from Sales and Divestitures amounted to $224,537 in Q4 2023, which was up 25.90% from $178,343 recorded in Q4 2022.
  • Zepp Health's Gains from Sales and Divestitures' 5-year high stood at $1.6 million during Q4 2019, with a 5-year trough of $80,968 in Q4 2021.
  • For the 3-year period, Zepp Health's Gains from Sales and Divestitures averaged around $161,283, with its median value being $178,343 (2022).
  • Its Gains from Sales and Divestitures has fluctuated over the past 5 years, first surged by 871.16% in 2019, then tumbled by 90.79% in 2020.
  • Over the past 5 years, Zepp Health's Gains from Sales and Divestitures (Quarterly) stood at $1.6 million in 2019, then tumbled by 90.79% to $148,926 in 2020, then tumbled by 45.63% to $80,968 in 2021, then spiked by 120.26% to $178,343 in 2022, then rose by 25.90% to $224,537 in 2023.
  • Its Gains from Sales and Divestitures stands at $224,537 for Q4 2023, versus $178,343 for Q4 2022 and $80,968 for Q4 2021.